• What Drives Us
• Leadership
  • Our Team
  • Board of Directors
  • Scientific Advisory Board
• Science
  • The Science of Chronokines
  • Proteomic Discovery: Chronokines
  • Our Focus: Critical Diseases of Aging
• Pipeline
  • Clinical Progress
  • AKST4290: Targeting Eotaxin
  • GRF6019 & GRF6021: Selected Plasma Fractions
  • AKST1210: Targeting Beta-2 Microglobulin
  • Clinical Trials
• News & Events
  • Latest News
  • Publications & Presentations
• Careers & Culture
  • Life at Alkahest
  • Benefits of Joining the Alkahest Family
  • Join Our Team in Making a Difference
• Partners & Partnering
  • Current Partnerships
  • Partnering with Alkahest
• Contact